» Articles » PMID: 24662523

Multiple Toxin-antitoxin Systems in Mycobacterium Tuberculosis

Overview
Journal Toxins (Basel)
Publisher MDPI
Specialty Toxicology
Date 2014 Mar 26
PMID 24662523
Citations 138
Authors
Affiliations
Soon will be listed here.
Abstract

The hallmark of Mycobacterium tuberculosis is its ability to persist for a long-term in host granulomas, in a non-replicating and drug-tolerant state, and later awaken to cause disease. To date, the cellular factors and the molecular mechanisms that mediate entry into the persistence phase are poorly understood. Remarkably, M. tuberculosis possesses a very high number of toxin-antitoxin (TA) systems in its chromosome, 79 in total, regrouping both well-known (68) and novel (11) families, with some of them being strongly induced in drug-tolerant persisters. In agreement with the capacity of stress-responsive TA systems to generate persisters in other bacteria, it has been proposed that activation of TA systems in M. tuberculosis could contribute to its pathogenesis. Herein, we review the current knowledge on the multiple TA families present in this bacterium, their mechanism, and their potential role in physiology and virulence.

Citing Articles

Applications of toxin-antitoxin systems in synthetic biology.

Lin J, Guo Y, Yao J, Tang K, Wang X Eng Microbiol. 2024; 3(2):100069.

PMID: 39629251 PMC: 11610964. DOI: 10.1016/j.engmic.2023.100069.


Unlocking the Mycobacteroides abscessus pan-genome using computational tools: insights into evolutionary dynamics and lifestyle.

Karmakar M, Sur S Antonie Van Leeuwenhoek. 2024; 118(1):30.

PMID: 39579164 DOI: 10.1007/s10482-024-02042-z.


Nucleotidyltransferase toxin MenT extends aminoacyl acceptor ends of serine tRNAs to control Mycobacterium tuberculosis growth.

Xu X, Barriot R, Voisin B, Arrowsmith T, Usher B, Gutierrez C Nat Commun. 2024; 15(1):9596.

PMID: 39505885 PMC: 11541572. DOI: 10.1038/s41467-024-53931-w.


Association between toxin-antitoxin system mutations and global transmission of MDR-TB.

Li Y, Shao Y, Li Y, Kong X, Tao N, Hou Y BMC Infect Dis. 2024; 24(1):1250.

PMID: 39501228 PMC: 11539496. DOI: 10.1186/s12879-024-10142-4.


Deciphering the role of VapBC13 and VapBC26 toxin antitoxin systems in the pathophysiology of Mycobacterium tuberculosis.

Sharma A, Singh N, Bhasin M, Tiwari P, Chopra P, Varadarajan R Commun Biol. 2024; 7(1):1417.

PMID: 39478197 PMC: 11525840. DOI: 10.1038/s42003-024-06998-6.


References
1.
Sberro H, Leavitt A, Kiro R, Koh E, Peleg Y, Qimron U . Discovery of functional toxin/antitoxin systems in bacteria by shotgun cloning. Mol Cell. 2013; 50(1):136-48. PMC: 3644417. DOI: 10.1016/j.molcel.2013.02.002. View

2.
Korch S, Contreras H, Clark-Curtiss J . Three Mycobacterium tuberculosis Rel toxin-antitoxin modules inhibit mycobacterial growth and are expressed in infected human macrophages. J Bacteriol. 2008; 191(5):1618-30. PMC: 2648211. DOI: 10.1128/JB.01318-08. View

3.
Smollett K, Fivian-Hughes A, Smith J, Chang A, Rao T, Davis E . Experimental determination of translational start sites resolves uncertainties in genomic open reading frame predictions - application to Mycobacterium tuberculosis. Microbiology (Reading). 2009; 155(Pt 1):186-197. PMC: 2897130. DOI: 10.1099/mic.0.022889-0. View

4.
Blower T, Salmond G, Luisi B . Balancing at survival's edge: the structure and adaptive benefits of prokaryotic toxin-antitoxin partners. Curr Opin Struct Biol. 2011; 21(1):109-18. DOI: 10.1016/j.sbi.2010.10.009. View

5.
Fivian-Hughes A, Davis E . Analyzing the regulatory role of the HigA antitoxin within Mycobacterium tuberculosis. J Bacteriol. 2010; 192(17):4348-56. PMC: 2937366. DOI: 10.1128/JB.00454-10. View